UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs ...

Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Shares of Humana Inc. HUM shed 1.51% to $249.53 Friday, on what proved to be an all-around grim trading session for the stock ...

Humana Inc. closed 37.79% short of its 52-week high of $406.46, which the company reached on July 18th.

High-rolling investors have positioned themselves bullish on Humana ... performance Trading volume stands at 342,251, with HUM's price down by -1.52%, positioned at $249.5. RSI indicators show the ...

2024 when TD Cowen changed their price target from $402 to $261 for Humana Inc. Analysts arrive at stock ratings after doing extensive research, which includes going through public financial ...

It created a fandom culture around his accused shooter, Luigi Mangione, and an endless cycle of cheerleading and scolding in response. Prosecutors have prosecuted. Editorial boards have editorialized.

Davis Selected Advisers’ 13F portfolio value increased to $17.35B, with the number of holdings rising from 100 to 104. Learn ...

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases. Surging medical costs and regulatory changes hit ...

Wall Street firms are trying to put private credit, equity and real estate into the hands of individual investors. Surging medical costs and regulatory changes hit UnitedHealth, but rivals such as ...

Most of the top-earning executives at some of the nation’s largest for-profit healthcare organizations saw their overall compensation packages increase in 2024, according to proxy statements filed ...